首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Nuclease-Resistant Single-Stranded DNA Controls for Nucleic Acid Amplification Assays
【2h】

Nuclease-Resistant Single-Stranded DNA Controls for Nucleic Acid Amplification Assays

机译:抗核酸酶的单链DNA对照用于核酸扩增测定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Molecular diagnostic tests based on the PCR or alternative nucleic acid amplification technologies are commonly used for pathogen screening at blood drawing centers. Contrived process surveillance using test-specific external and internal controls is critical for the efficient leverage of PCR power. We describe here novel control constructs for use in nucleic acid amplification assays for pathogens with a single-stranded DNA genome, e.g., parvovirus B19. These controls are derived from a deletion mutant of the filamentous phage fd-tet, fKN16, and consist of single-stranded DNA packaged in a protein coat. They are essentially noninfectious to Escherichia coli and highly resistant to nuclease degradation. fKN16 based controls can be readily manufactured and highly purified. Despite their confirmed filamentous morphology, they can be precisely and accurately diluted over a wide range. Stability studies reveal that the novel control constructs are highly resistant to temperature stress, regardless of whether they are tested as concentrated stocks in storage buffer or diluted in buffer or human plasma. Real-time amplification curves derived from recombinant control constructs containing a parvovirus B19 specific sequence fragment match those derived from native virus. In summary, our data demonstrate the feasibility of novel nuclease-resistant single-stranded DNA controls as surrogates for parvovirus B19 and their applicability in routine molecular diagnostics.
机译:基于PCR或替代核酸扩增技术的分子诊断测试通常用于抽血中心的病原体筛查。使用特定于测试的外部和内部控制进行人为的过程监视对于有效利用PCR功能至关重要。我们在此描述了用于具有单链DNA基因组例如细小病毒B19的病原体的核酸扩增测定中的新型对照构建体。这些对照来自丝状噬菌体fd-tet fKN16的缺失突变体,由包装在蛋白质外壳中的单链DNA组成。它们基本上对大肠杆菌无感染性,并且对核酸酶降解具有高度抵抗力。基于fKN16的对照可以容易地制造和高度纯化。尽管它们具有丝状形态,但可以在很宽的范围内精确地稀释它们。稳定性研究表明,无论将其作为浓缩缓冲液在储存缓冲液中进行测试还是在缓冲液或人血浆中进行稀释,新的对照构建体均对温度胁迫具有高度抵抗力。衍生自包含细小病毒B19特异性序列片段的重组对照构建体的实时扩增曲线与衍生自天然病毒的实时扩增曲线相匹配。总而言之,我们的数据证明了新颖的抗核酸酶的单链DNA控件作为细小病毒B19的替代品的可行性及其在常规分子诊断中的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号